Chemotherapy oxaliplatin sensitizes prostate cancer to immune checkpoint blockade therapies via stimulating tumor immunogenicity
Article in Molecular Medicine Reports (March 2017)
The most recent citing publications are shown below. View all 2 publications that cite this research output on Dimensions.
Article in Molecular Medicine Reports (March 2017)
Article in Expert Opinion on Biological Therapy (November 2016)